Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 6/20 | 0.57 |
| ▸ | JAK2 | O60674 | 5/20 | 0.51 |
| ▸ | HPGDS | O60760 | 1/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1664406 | 0.92 | NPC1 (0.53) | BRD4HPGDSMAPK14KDRFLT3 | |
| SCHEMBL1666855 | 0.90 | BRD4 (0.47) | BRD4JAK2HPGDSMAPK14RAB9A | |
| SCHEMBL1666853 | 0.90 | BRD4 (0.45) | BRD4JAK2HPGDSRAB9ASMYD3 | |
| SCHEMBL1666783 | 0.89 | SMYD3 (0.46) | BRD4JAK2HPGDSRAB9ASMYD3 | |
| SCHEMBL1667320 | 0.84 | HPGDS (0.49) | BRD4JAK2HPGDSMAPK14NPC1 | |
| SCHEMBL1664447 | 0.82 | SMYD3 (0.43) | BRD4JAK2HPGDSRAB9ASMYD3 | |
| SCHEMBL13836635 | 0.82 | SMYD3 (0.44) | BRD4HPGDSKDRFLT3NPC1 | |
| SCHEMBL13836637 | 0.82 | SMYD3 (0.44) | BRD4HPGDSKDRFLT3NPC1 | |
| SCHEMBL1666784 | 0.82 | SMYD3 (0.46) | BRD4HPGDSMAPK14KDRFLT3 | |
| SCHEMBL1664448 | 0.80 | HPGDS (0.46) | BRD4JAK2HPGDSMAPK14RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2642994-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | Ligand Pharmaceuticals Incorporated (US) | 2013-10-02 | — | — | EP | disclosed |
| EP-2488486-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | Ligand Pharmaceuticals Inc. (US) | 2012-08-22 | — | — | EP | disclosed |
| WO-2012068406-A2 | USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011046954-A1 | HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES | LIGAND PHARMACEUTICALS INC. (US) | 2011-04-21 | — | — | WO | disclosed |